Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Leyla H. Sharaf"'
Autor:
Nada A. Al-Hasawi, Sanaa A. Amine, Leyla H. Sharaf, Ladislav Novotny, Oludotun A. Phillips, Fatma H. Al-Awadhi
Publikováno v:
Anticancer research. 40(9)
BACKGROUND/AIM Neuroblastoma (NB), the most common extracranial malignant childhood tumor accounts for about 15% of cancer-related deaths in children. Despite the intensive treatment of patients with high-risk scarification of NB, clinical outcomes i
Publikováno v:
General physiology and biophysics. 37:93-99
Triorganotins belong to toxic components present predominantly in antifouling paints for marine vessels. Tributyltin/triphenyltin at pico- or nanomolar concentrations in sea water are known to induce an irreversible sexual abnormality in females of o
Autor:
Roselyn Jennifer D’silva, Leyla H. Sharaf, Ludmil Benov, Oludotun A. Phillips, D. Eric Walters, Teklu O. Bahta, Edet E. Udo
Publikováno v:
European Journal of Medicinal Chemistry. 106:120-131
Research activities on the oxazolidinone antibacterial class of compounds continue to focus on developing newer derivatives with improved potency, broad-spectrum activity and safety profiles superior to linezolid. Among the safety concerns with the o
Publikováno v:
European Journal of Pharmaceutical Sciences. 71:56-61
Oxazolidinone class of compounds continue to generate interest as promising agents effective against sensitive and resistant Gram-positive pathogenic bacteria strains. Recent focus is to develop new potent derivatives with improved broad-spectrum act
Autor:
Leyla H. Sharaf, Oludotun A. Phillips
Publikováno v:
Expert opinion on therapeutic patents. 26(5)
Antimicrobial resistance in Gram-positive bacteria is a major health care issue. This review summarizes patent publications from 2012 to 2015 that divulged novel oxazolidinones as antibacterial agents.A total of 25 patents obtained from Espacenet, WI
Autor:
Leyla H. Sharaf, Oludotun A. Phillips
Publikováno v:
Expert Opinion on Therapeutic Patents. 19:529-540
The application, WO2008062379, claims chimeric compounds comprising chemically linked 5-hydroxymethyl-oxazolidinone and tetracyclic-quinolone moieties. The claimed compounds are potent expanded-range antibacterial agents against selected gram-positiv
Publikováno v:
International journal of oncology. 38(5)
Both de novo and acquired endocrine resistance constitute a major therapeutic problem for treatment of hormone-positive breast cancer. Multiple explanatory mechanisms have been proposed through the study of cellular models which focus principally on
Publikováno v:
Journal of Urology. 183
Publikováno v:
Medical principles and practice : international journal of the Kuwait University, Health Science Centre. 20(1)
Objectives: To evaluate the stability of 12 triazolyl oxazolidinone (TOZ) derivatives in simulated gastric and intestinal fluids as well as in human plasma at 37 ± 1°C. Materials and Methods: A stability-indicating high-performance liquid chromatog